(Q40629375)

22 September 2017

Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin (English)

1 reference

22 September 2017

0 references

1

Belongia EA

1 reference

22 September 2017

Reed KD

2

1 reference

22 September 2017

Mitchell PD

3

1 reference

22 September 2017

Chyou PH

4

1 reference

22 September 2017

Mueller-Rizner N

5

1 reference

22 September 2017

Finkel MF

6

1 reference

22 September 2017

Schriefer ME

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

Clinical Infectious Diseases

22 September 2017

1 reference

22 September 2017

29

1 reference

22 September 2017

6

1 reference

22 September 2017

1472-1477

1 reference

Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

22 September 2017

1 reference

Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle

21 January 2018

1 reference

Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

21 January 2018

1 reference

Methods of adjustment for estimating the attributable risk in case-control studies: A review

21 January 2018

1 reference

Clinical and laboratory characteristics of human granulocytic ehrlichiosis

21 January 2018

1 reference

Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin

21 January 2018

1 reference

Emergence of Lyme disease in Hunterdon County, New Jersey, 1993: a case-control study of risk factors and evaluation of reporting patterns

21 January 2018

1 reference

Pressurized sprays of permethrin or deet on military clothing for personal protection against Ixodes dammini (Acari: Ixodidae).

21 January 2018

1 reference

Case-control study of risk factors for incident Lyme disease in California.

21 January 2018

1 reference

Predisposing factors for individuals' Lyme disease prevention practices: Connecticut, Maine, and Montana.

21 January 2018

1 reference

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

21 January 2018

1 reference

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313532

1 reference

22 September 2017

1 reference